Cargando…
Enhanced accumulation of reduced glutathione by Scopoletin improves survivability of dopaminergic neurons in Parkinson’s model
Parkinson’s disease (PD) is a neuromotor disorder, primarily manifested by motor anomalies due to progressive loss of dopaminergic neurons. Although alterations in genetic factors have been linked with its etiology, exponential accumulation of environmental entities such as reactive oxygen species (...
Autores principales: | Pradhan, Priyadarshika, Majhi, Olivia, Biswas, Abhijit, Joshi, Vinod Kumar, Sinha, Devanjan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7484898/ https://www.ncbi.nlm.nih.gov/pubmed/32913179 http://dx.doi.org/10.1038/s41419-020-02942-8 |
Ejemplares similares
-
Advances in biosynthesis of scopoletin
por: He, Bo-Tao, et al.
Publicado: (2022) -
Pharmacogenomics of Scopoletin in Tumor Cells
por: Seo, Ean-Jeong, et al.
Publicado: (2016) -
Parkinson's disease and dopaminergic neurons
Publicado: (2012) -
Parkinson’s Disease, the Dopaminergic Neuron and Gammahydroxybutyrate
por: Mamelak, Mortimer
Publicado: (2018) -
Glutathione depletion and overproduction both initiate degeneration of nigral dopaminergic neurons
por: Garrido, Manuel, et al.
Publicado: (2010)